210 related articles for article (PubMed ID: 31019310)
21. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
Loidl W; Schmidbauer J; Susani M; Marberger M
Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden.
Malmström PU; Hedelin H; Thomas YK; Thompson GJ; Durrant H; Furniss J
Scand J Urol Nephrol; 2009; 43(3):192-8. PubMed ID: 19330681
[TBL] [Abstract][Full Text] [Related]
23. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
Bach T; Bastian PJ; Blana A; Kaminsky A; Keller S; Knoll T; Lang C; Promnitz S; Ubrig B; Keller T; Qvick B; Burger M;
World J Urol; 2017 May; 35(5):737-744. PubMed ID: 27578233
[TBL] [Abstract][Full Text] [Related]
24. Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance.
Malmström PU; Grabe M; Haug ES; Hellström P; Hermann GG; Mogensen K; Raitanen M; Wahlqvist R
Scand J Urol Nephrol; 2012 Apr; 46(2):108-16. PubMed ID: 22087730
[TBL] [Abstract][Full Text] [Related]
25. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study.
Geavlete B; Jecu M; Multescu R; Georgescu D; Geavlete P
Urology; 2010 Sep; 76(3):664-9. PubMed ID: 20627289
[TBL] [Abstract][Full Text] [Related]
26. Underutilization of Blue Light Cystoscopy for Bladder Cancer in the United States.
Lewicki P; Arenas-Gallo C; Qiu Y; Venkat S; Basourakos SP; Scherr D; Shoag JE
Eur Urol Focus; 2022 Jul; 8(4):968-971. PubMed ID: 34711530
[TBL] [Abstract][Full Text] [Related]
27. Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study.
Pohar KS; Patel S; Lotan Y; Trabulsi E; Woods M; Downs T; Huang WC; Jones J; Taylor J; O'Donnell M; Bivalacqua TJ; DeCastro J; Steinberg G; Kamat AM; Resnick MJ; Konety B; Schoenberg M; Jones JS; Daneshmand S;
Urol Oncol; 2022 Aug; 40(8):382.e1-382.e6. PubMed ID: 35750559
[TBL] [Abstract][Full Text] [Related]
28. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study.
Witjes JA; Moonen PM; van der Heijden AG
Eur Urol; 2005 Mar; 47(3):319-22. PubMed ID: 15716194
[TBL] [Abstract][Full Text] [Related]
29. Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer.
Yang LP
Mol Diagn Ther; 2014 Feb; 18(1):105-16. PubMed ID: 24248555
[TBL] [Abstract][Full Text] [Related]
30. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.
Daneshmand S; Bazargani ST; Bivalacqua TJ; Holzbeierlein JM; Willard B; Taylor JM; Liao JC; Pohar K; Tierney J; Konety B;
Urol Oncol; 2018 Aug; 36(8):361.e1-361.e6. PubMed ID: 29859728
[TBL] [Abstract][Full Text] [Related]
31. Blue light cystoscopy with hexylaminolevulinate: Our 7 years experience.
Lacetera V; Cantoro U; Montesi L; Cantoro D; Cervelli B; Cicetti A; Gabrielloni G; Milella D; Montesi M; Morcellini R; Parri G; Recanatini E; Beatrici V
Arch Ital Urol Androl; 2017 Mar; 89(1):39-41. PubMed ID: 28403596
[TBL] [Abstract][Full Text] [Related]
32. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.
Stenzl A; Burger M; Fradet Y; Mynderse LA; Soloway MS; Witjes JA; Kriegmair M; Karl A; Shen Y; Grossman HB
J Urol; 2010 Nov; 184(5):1907-13. PubMed ID: 20850152
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study.
Daneshmand S; Patel S; Lotan Y; Pohar K; Trabulsi E; Woods M; Downs T; Huang W; Jones J; O'Donnell M; Bivalacqua T; DeCastro J; Steinberg G; Kamat A; Resnick M; Konety B; Schoenberg M; Jones JS;
J Urol; 2018 May; 199(5):1158-1165. PubMed ID: 29203268
[TBL] [Abstract][Full Text] [Related]
34. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
Mark JR; Gelpi-Hammerschmidt F; Trabulsi EJ; Gomella LG
Can J Urol; 2012 Apr; 19(2):6227-31. PubMed ID: 22512972
[TBL] [Abstract][Full Text] [Related]
35. Implementing hexaminolevulinate HCl blue light cystoscopy: a nursing perspective.
Calvaresi AE; Trabulsi EJ; Sonzogni M; Gomella LG; Lallas CD; Wachsmuth KS
AORN J; 2014 Nov; 100(5):489-96; quiz 497-9. PubMed ID: 25443119
[TBL] [Abstract][Full Text] [Related]
36. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F
Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343
[TBL] [Abstract][Full Text] [Related]
37. Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data.
Witjes JA; Gomella LG; Stenzl A; Chang SS; Zaak D; Grossman HB
Urology; 2014 Jul; 84(1):122-6. PubMed ID: 24768013
[TBL] [Abstract][Full Text] [Related]
38. 'Real-life experience': recurrence rate at 3 years with Hexvix
Gallagher KM; Gray K; Anderson CH; Lee H; Stewart S; Donat R; Mariappan P
World J Urol; 2017 Dec; 35(12):1871-1877. PubMed ID: 28803385
[TBL] [Abstract][Full Text] [Related]
39. Can routine outpatient follow-up of patients with bladder cancer be improved? A multicenter prospective observational assessment of blue light flexible cystoscopy and fulguration.
Zare R; Grabe M; Hermann GG; Malmström PU
Res Rep Urol; 2018; 10():151-157. PubMed ID: 30349812
[TBL] [Abstract][Full Text] [Related]
40. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy.
Grossman HB; Stenzl A; Fradet Y; Mynderse LA; Kriegmair M; Witjes JA; Soloway MS; Karl A; Burger M
J Urol; 2012 Jul; 188(1):58-62. PubMed ID: 22583635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
